Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AYTU BIOPHARMA, INCAytu BioPharma Reports 33% Revenue Decline and $5.6 Million Net Loss for Q3 2026
OMEROS CORPOmeros Corporation Reports $9.9M in Product Sales and $56.1M Net Income for Q1 2026
SPRUCE BIOSCIENCES, INC.Spruce Biosciences Reports $12.3 Million Net Loss in Q1 2026, Focuses on TA-ERT Development
Dermata Therapeutics, Inc.Dermata Therapeutics Reports $1.8 Million Net Loss in Q1 2026, Shifts Focus to DTC Skincare
Grocery Outlet Holding Corp.Grocery Outlet Reports $180.3 Million Net Loss in Q1 Fiscal 2026 Amid Restructuring Efforts
B&G Foods, Inc.B&G Foods Reports $32.5 Million Net Loss in First Quarter of 2026
Snail, Inc.Snail, Inc. Reports 35.7% Revenue Growth and Net Income Turnaround in Q1 2026
TELA Bio, Inc.TELA Bio Reports 3% Revenue Growth to $19.1 Million in Q1 2026
Avidbank Holdings, Inc.Avidbank Holdings Reports $9.0 Million Net Income in Q1 2026, Driven by 37% Rise in Net Interest Income
Linkhome Holdings Inc.Linkhome Holdings Reports 14% Revenue Decline and Net Loss in Q1 2026
STAAR SURGICAL COSTAAR Surgical Reports 119.6% Revenue Growth to $93.5 Million in Latest Quarter
WisdomTree Bitcoin FundWisdomTree Bitcoin Fund Reports $147.3 Million Net Asset Value Amid Market Volatility
TAP REAL ESTATE TECHNOLOGIES, INC.TAP Real Estate Technologies Reports $2.96 Million Net Loss in Q1 2026
REED'S, INC.Reed's, Inc. Reports $6.464 Million Net Loss in Q1 2026 Amid Revenue Decline
Nixxy, Inc.Nixxy, Inc. Reports 2,205% Revenue Growth to $29.1 Million in Latest Quarter
Finward BancorpFinward Bancorp Reports 392.7% Increase in Net Income for Q1 2026
AmpliTech Group, Inc.AmpliTech Group Reports 48.6% Revenue Growth to $5.35 Million in Latest Quarter
Allogene Therapeutics, Inc.Allogene Therapeutics Reports $42.6 Million Net Loss in Q1 2026, Improves from Previous Year
OptimizeRx CorpOptimizeRx Reports $19.8 Million Revenue in Q1 2026, Down 10% Year-Over-Year
Spero Therapeutics, Inc.Spero Therapeutics Reports Revenue Decline to $258,000 in Q1 2026
NetBrands Corp.NetBrands Corp. Reports $13.8M Mining Revenue and Increased Losses in Q1 2026
Longeveron Inc.Longeveron Reports Q1 2026 Financial Results with Revenue Increase and Net Loss Improvement
Winchester Bancorp, Inc./MD/Winchester Bancorp Reports Significant Increase in Net Income and Assets for Q1 2026
Worksport LtdWorksport Ltd. Reports 48% Increase in Net Sales but Higher Operational Losses in Q1 2026
Oruka Therapeutics, Inc.Oruka Therapeutics Reports $31.8 Million Net Loss in Q1 2026, Increases Investment in Clinical Trials